Cargando…
Noninvasive quantification of (18)F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma
PURPOSE: Compartmental modelling of 3′-deoxy-3′-[(18)F]-fluorothymidine ((18)F-FLT) PET-derived kinetics provides a method for noninvasive assessment of the proliferation rate of gliomas. Such analyses, however, require an input function generally derived by serial blood sampling and counting. In th...
Autores principales: | Backes, Heiko, Ullrich, Roland, Neumaier, Bernd, Kracht, Lutz, Wienhard, Klaus, Jacobs, Andreas H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779371/ https://www.ncbi.nlm.nih.gov/pubmed/19672593 http://dx.doi.org/10.1007/s00259-009-1244-4 |
Ejemplares similares
-
Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[(18)F]-Fluoro-L-Thymidine ([(18)F]FLT) Positron Emission Tomography (PET)
por: Ullrich, Roland T., et al.
Publicado: (2008) -
An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014) -
Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
por: Neumaier, Felix, et al.
Publicado: (2023) -
Erratum to: Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
por: Galldiks, Norbert, et al.
Publicado: (2010) -
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours
por: Hoh, C K, et al.
Publicado: (2014)